Activity of highly selective LSD1 inhibitors in HCT-116 xenograft mice.

被引：0

作者：

Maes, T. ^{[1
]}

Castro, J. ^{[1
]}

Ortega, A. ^{[1
]}

Guibourt, N. ^{[1
]}

机构：

[1] Oryzon Gen SA, Cornelia De Llobregat, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.e13663

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e13663

引用

页数：1

共 50 条

[31] Selective inhibitors of nuclear export (SINE) display single agent efficacy against gastric (NCI-N87) and colon (HCT-116) xenografts.
McCauley, Dilara
Kashyap, Trinayan
Hamuza, Mwanasha
Landesman, Yosef
Ippolitti, Paul
Shechter, Sharon
Saint-Martin, Jean Richard
Crochiere, Marsha
Senapedis, William
Klebanov, Boris
Tamir, Sharon
Del Alamo, Diego
Baloglu, Erkan
Draetta, Giulio
Kauffman, Michael
Shacham, Sharon
CANCER RESEARCH, 2013, 73 (08)
[32] Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia
Xu, Siyuan
Zhou, Chen
Liu, Rongfeng
Zhu, Qihua
Xu, Yungen
Lan, Fei
Zha, Xiaoming
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (17) : 4871 - 4880
[33] Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors
Duan, Yingchao
Yu, Tong
Jin, Linfeng
Zhang, Shaojie
Shi, Xiaojing
Zhang, Yizhe
Zhou, Nanqian
Xu, Yongtao
Lu, Wenfeng
Zhou, Huimin
Zhu, Huijuan
Bai, Suping
Hu, Kua
Guan, Yuanyuan
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 254
[34] Synthesis, optimization and antitumor activity evaluation of sulfonyl benzoyl hydrazide derivatives as novel human LSD1 inhibitors
Ai, Wei
Zuo, Zeping
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 114
[35] Pyrimidinedione-mediated selective histone deacetylase 6 inhibitors with antitumor activity in colorectal cancer HCT116 cells
Liu, Yi-Min
Lee, Hsueh-Yun
Lai, Mei-Jung
Pan, Shiow-Lin
Huang, Hsiang-Ling
Kuo, Fei-Chiao
Chen, Mei-Chuan
Liou, Jing-Ping
ORGANIC & BIOMOLECULAR CHEMISTRY, 2015, 13 (40) : 10226 - 10235
[36] Design, synthesis and in vitro/in vivo anticancer activity of tranylcypromine-based triazolopyrimidine analogs as novel LSD1 inhibitors
Li, Zhonghua
Yuan, Yong
Wang, Pan
Zhang, Zijuan
Ma, Huifen
Sun, Yiran
Zhang, Xiaowei
Li, Xiaofang
Qiao, Yonghui
Zhang, Feiyu
Su, Yunfang
Song, Junying
Xie, Zhishen
Li, Lixin
Ma, Liying
Ma, Jinlian
Zhang, Zhenqiang
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 253
[37] Exploring cyclopropylamine containing cyanopyrimidines as LSD1 inhibitors: Design, synthesis, ADMET, MD analysis and anticancer activity profiling
Sheikh, Khursheed Ahmad
Parveen, Darakhshan
Alam, M. Mumtaz
Azam, Faizul
Khan, Mohammad Ahmed
Akhter, Mymoona
Tasneem, Sharba
Meenu
Parvez, Suhel
Imtiyaz, Khalid
Rizvi, Moshahid A.
Shaquiquzzaman, M.
BIOORGANIC CHEMISTRY, 2024, 147
[38] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT-116 xenograft model in nude mice (vol 36, pg 2951, 2016)
Yassin, Sitelbanat
Hu, Jialiang
Xu, Hanmei
Li, Ce
Setrerrahmane, Sarra
ONCOLOGY REPORTS, 2020, 43 (04) : 1349 - 1349
[39] Effects of novel triazole-dithiocarbamate based LSD1 selective inhibitors on gastric cancer cell growth, invasion and migration in vitro
Zheng, Yi-chao
Lv, Wen-lei
Ma, Jin-lian
Yang, Ang
Li, Jin-feng
Wang, Zhi-ru
Zhao, Wen
Liu, Hong-min
ACTA PHARMACOLOGICA SINICA, 2013, 34 : 137 - 138
[40] Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation
Schulz-Fincke, Johannes
Hau, Mirjam
Barth, Jessica
Robaa, Dina
Willmann, Dominica
Kuerner, Andreas
Haas, CJulian
Greve, Gabriele
Haydn, Tinka
Fulda, Simone
Luebbert, Michael
Luedeke, Steffen
Berg, Tobias
Sippl, Wolfgang
Schuele, Roland
Jung, Manfred
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 144 : 52 - 67

← 1 2 3 4 5 →